Merz Pharmaceuticals Announces Phase III Data For NT 201 In Post-stroke Upper Limb Spasticity
Links shared publicly online about this topic.
- 1,694total visits
Merz Pharmaceuticals Announces Phase III Data For NT 201 In Post-stroke Upper Limb Spasticity
Data results published this month in Clinical Neuropharmacology, revealed that Merz Pharmaceuticals' NT 201 (botulinum toxin type A free from complexing proteins), also known by the brand n
View full resource at medicalnewstoday.com
Tags: Poison, Botulism, Protein, Pharma
Most Recently Shared on October 7, 2009 at 1:59 pm By:
Merz Pharmaceuticals Announces Phase III Data For NT 201 In Post-stroke Upper Limb Spasticity: Data results pub.. http://bit.ly/1aaB36
Advertisement
